4'Cl-CUMYL-PINACA
Chemical compound
From Wikipedia, the free encyclopedia
4'Cl-CUMYL-PINACA (also known as SGT-157) is an indazole-3-carboxamide based synthetic cannabinoid compound, first disclosed in a 2014 patent.[1] It has been sold as a designer drug, first reported in 2020 alongside two similar compounds 4'F-CUMYL-5F-PICA (SGT-64) and 4'F-CUMYL-5F-PINACA (SGT-65),[2] and the metabolism of these compounds has been studied to assist with their identification in forensic casework.[3]


Legal status
- CA: Schedule II
- DE: NpSG (Industrial and scientific use only)
- UK: Class B
| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C22H26ClN3O |
| Molar mass | 383.92 g·mol−1 |
| 3D model (JSmol) | |
| |
| |